Barclays’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4K | Buy |
286
+285
| +28,500% | +$3.99K | ﹤0.01% | 4233 |
|
|
2025
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4441 |
|
|
2024
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4403 |
|
|
2024
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4365 |
|
|
2024
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4234 |
|
|
2024
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4202 |
|
|
2023
Q4 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 4251 |
|
|
2023
Q3 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 4302 |
|
|
2023
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 4298 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4343 |
|
|
2022
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4427 |
|
|
2021
Q4 | – | Sell |
-48
| Closed | -$11K | – | 3473 |
|
|
2021
Q3 | $11K | Sell |
48
-140
| -74% | -$32.1K | ﹤0.01% | 3736 |
|
|
2021
Q2 | $44K | Sell |
188
-122
| -39% | -$28.6K | ﹤0.01% | 3439 |
|
|
2021
Q1 | $93K | Buy |
310
+190
| +158% | +$57K | ﹤0.01% | 3387 |
|
|
2020
Q4 | $45K | Sell |
120
-82
| -41% | -$30.8K | ﹤0.01% | 3213 |
|
|
2020
Q3 | $62K | Sell |
202
-53
| -21% | -$16.3K | ﹤0.01% | 3202 |
|
|
2020
Q2 | $96K | Buy |
255
+84
| +49% | +$31.6K | ﹤0.01% | 3138 |
|
|
2020
Q1 | $39K | Sell |
171
-404
| -70% | -$92.1K | ﹤0.01% | 3193 |
|
|
2019
Q4 | $304K | Buy |
575
+172
| +43% | +$90.9K | ﹤0.01% | 2970 |
|
|
2019
Q3 | $174K | Buy |
403
+60
| +17% | +$25.9K | ﹤0.01% | 3123 |
|
|
2019
Q2 | $410K | Sell |
343
-204
| -37% | -$244K | ﹤0.01% | 2832 |
|
|
2019
Q1 | $681K | Buy |
547
+423
| +341% | +$527K | ﹤0.01% | 2427 |
|
|
2018
Q4 | $118K | Sell |
124
-143
| -54% | -$136K | ﹤0.01% | 2913 |
|
|
2018
Q3 | $384K | Sell |
267
-5
| -2% | -$7.19K | ﹤0.01% | 2763 |
|
|
2018
Q2 | $438K | Sell |
272
-269
| -50% | -$433K | ﹤0.01% | 2362 |
|
|
2018
Q1 | $878K | Sell |
541
-69
| -11% | -$112K | ﹤0.01% | 1902 |
|
|
2017
Q4 | $1.03M | Buy |
610
+293
| +92% | +$492K | ﹤0.01% | 1626 |
|
|
2017
Q3 | $443K | Buy |
317
+40
| +14% | +$55.9K | ﹤0.01% | 1982 |
|
|
2017
Q2 | $309K | Buy |
277
+190
| +218% | +$212K | ﹤0.01% | 2185 |
|
|
2017
Q1 | $47K | Buy |
87
+16
| +23% | +$8.64K | ﹤0.01% | 3116 |
|
|
2016
Q4 | $44K | Buy |
71
+1
| +1% | +$620 | ﹤0.01% | 2879 |
|
|
2016
Q3 | $50K | Sell |
70
-88
| -56% | -$62.9K | ﹤0.01% | 2712 |
|
|
2016
Q2 | $115K | Buy |
158
+69
| +78% | +$50.2K | ﹤0.01% | 2292 |
|
|
2016
Q1 | $45K | Hold |
89
| – | – | ﹤0.01% | 2567 |
|
|
2015
Q4 | $45K | Buy |
89
+27
| +44% | +$13.7K | ﹤0.01% | 2524 |
|
|
2015
Q3 | $31K | Buy |
62
+13
| +27% | +$6.5K | ﹤0.01% | 2731 |
|
|
2015
Q2 | $34K | Buy |
+49
| New | +$34K | ﹤0.01% | 2766 |
|
|
2014
Q3 | – | Sell |
-83
| Closed | -$66K | – | 4377 |
|
|
2014
Q2 | $66K | Buy |
83
+81
| +4,050% | +$64.4K | ﹤0.01% | 2930 |
|
|
2014
Q1 | $4K | Buy |
+2
| New | +$4K | ﹤0.01% | 4048 |
|